Cardiovascular Safety of Bruton Tyrosine Kinase Inhibitors: From Ibrutinib to Next-Generation Agents.
Spadafora L, Russo F, Bukowska-Olech E, Panichella G, Garofalo M, Cacciatore S, Sabouret P, Sarto G, Simeone B, Rocco E, Lauretti A, Versaci F, Zoccai GB, Colaiori I, Valenti V, Sciarretta S, Bernardi M.
Spadafora L, et al.
Am J Cardiovasc Drugs. 2026 Jan;26(1):21-34. doi: 10.1007/s40256-025-00757-6. Epub 2025 Aug 28.
Am J Cardiovasc Drugs. 2026.
PMID: 40877482
Free PMC article.
Review.